Nursing and Health Professions
Rheumatoid Arthritis
100%
Methotrexate
57%
Patient
53%
Biological Marker
38%
DNA Methylation
30%
Treatment Response
27%
Tumor Necrosis Factor Inhibitor
27%
Enalapril Maleate
25%
DAS28
22%
Drug
19%
Combination Therapy
18%
Diseases
14%
Procedures
14%
Classifier
12%
Biological Product
12%
Methylation
11%
Time
10%
Adalimumab
10%
Sample
9%
Analysis
9%
Lipid Level
8%
Area under the Curve
8%
Lipid Blood Level
6%
Disease Modifying Antirheumatic Drug
6%
Gender
6%
Drug Therapy
5%
Classification
5%
Disease Activity
5%
Biochemistry, Genetics and Molecular Biology
Methotrexate
58%
DNA Methylation
49%
Association
47%
Nested Gene
31%
TNF Inhibitor
31%
Gene Expression
25%
Methylation
24%
Time
15%
Signal Transduction
14%
Adalimumab
13%
CD4
13%
Epigenetics
12%
Expression Quantitative Trait Loci
12%
Interleukin-18 Receptor
12%
Birth
12%
Transcription
12%
Transcriptome
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Erythrocyte Sedimentation Rate
10%
Life
9%
Position
9%
Genetics
8%
Sample
8%
Genetic Risk
8%
Lipid Level
8%
Light
8%
Lymphocyte
8%
B Cell
6%
DNA
6%
Blood Lipids
6%
Protein Expression
6%
Health
6%
Protein
6%
Electric Potential
5%
Genome-Wide Association Study
5%
Medicine and Dentistry
Rheumatoid Arthritis
58%
Patient
35%
Diseases
32%
DAS28
32%
DNA Methylation
29%
Therapeutic Procedure
27%
TNF Inhibitor
17%
Methotrexate
12%
Kabuki Syndrome
12%
Single Nucleotide Polymorphism
12%
Methylation
11%
Treatment Response
9%
Biological Marker
9%
Gene
9%
Joint
8%
Tumor Necrosis Factor
8%
Blood
8%
Exon
7%
Drug
6%
Chemotherapeutic Agent
6%
Association
6%
Drug Therapy
6%
Adalimumab
6%
Position
6%
Enalapril Maleate
6%
Pathogenesis
5%
C Reactive Protein
5%
Analysis
5%
Genetic Risk
5%
Cells
5%
B Cell
5%
Immune Dysregulation
5%
Clinical Feature
5%
Genome Wide Association Study
5%
